Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time
Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time. 18 months post-illness using a urea enzyme-linked immunosorbent… Read More »Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time